Insider Selling: Heartflow (NASDAQ:HTFL) CEO Sells $1,361,500.00 in Stock

Heartflow, Inc. (NASDAQ:HTFL) CEO John C.M. Farquhar sold 38,900 shares of Heartflow stock in a transaction that occurred on Wednesday, June 24th. The shares were sold at an average price of $35.00, for a total transaction of $1,361,500.00. Following the sale, the chief executive officer directly owned 457,935 shares of the company’s stock, valued at $16,027,725. This represents a 7.83% decrease in their position. The transaction was disclosed in a filing with the SEC, which is available at this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.

John C.M. Farquhar also recently made the following trade(s):

• On Wednesday, June 10th, John C.M. Farquhar sold 22,562 shares of Heartflow stock. The stock was sold at an average price of $28.50, for a total value of $643,017.00.
• On Monday, May 11th, John C.M. Farquhar sold 22,562 shares of Heartflow stock. The stock was sold at an average price of $29.12, for a total value of $657,005.44.
• On Friday, April 10th, John C.M. Farquhar sold 22,562 shares of Heartflow stock. The shares were sold at an average price of $26.72, for a total value of $602,856.64.

Heartflow Trading Up 0.1%

HTFL opened at $35.68 on Monday. The company has a market capitalization of $3.08 billion and a price-to-earnings ratio of -11.47. Heartflow, Inc. has a 12-month low of $20.13 and a 12-month high of $41.22. The business’s fifty day simple moving average is $30.69 and its 200-day simple moving average is $28.60.

Heartflow (NASDAQ:HTFL) last released its quarterly earnings data on Thursday, May 14th. The company reported ($0.16) earnings per share for the quarter, beating the consensus estimate of ($0.24) by $0.08. The firm had revenue of $52.59 million during the quarter. The firm’s quarterly revenue was up 41.3% compared to the same quarter last year. On average, equities research analysts predict that Heartflow, Inc. will post -0.82 EPS for the current year.

Institutional Trading of Heartflow

Institutional investors have recently made changes to their positions in the business. Essential Partners LLC purchased a new stake in shares of Heartflow during the first quarter worth about $57,000. Bank of America Corp DE grew its position in Heartflow by 28.8% during the 1st quarter. Bank of America Corp DE now owns 111,702 shares of the company’s stock worth $2,718,000 after purchasing an additional 24,964 shares during the last quarter. Janus Henderson Group PLC increased its stake in Heartflow by 152.0% during the 1st quarter. Janus Henderson Group PLC now owns 2,180,976 shares of the company’s stock valued at $53,063,000 after purchasing an additional 1,315,416 shares in the last quarter. California State Teachers Retirement System raised its holdings in shares of Heartflow by 41.9% in the first quarter. California State Teachers Retirement System now owns 29,371 shares of the company’s stock worth $715,000 after buying an additional 8,678 shares during the last quarter. Finally, Royal Bank of Canada lifted its stake in shares of Heartflow by 24.4% during the first quarter. Royal Bank of Canada now owns 137,421 shares of the company’s stock worth $3,343,000 after buying an additional 26,912 shares during the period.

Analyst Upgrades and Downgrades

Several brokerages have issued reports on HTFL. JPMorgan Chase & Co. dropped their target price on Heartflow from $40.00 to $35.00 and set an “overweight” rating on the stock in a research report on Thursday, March 19th. Canaccord Genuity Group reduced their price target on Heartflow from $43.00 to $37.00 and set a “buy” rating for the company in a research report on Friday, May 15th. Wells Fargo & Company upped their price objective on Heartflow from $35.00 to $37.00 and gave the stock an “overweight” rating in a research note on Friday, May 15th. William Blair started coverage on Heartflow in a research report on Monday, May 4th. They set an “outperform” rating on the stock. Finally, Piper Sandler reiterated an “overweight” rating on shares of Heartflow in a research note on Thursday, June 11th. Six investment analysts have rated the stock with a Buy rating, two have assigned a Hold rating and one has given a Sell rating to the company. According to data from MarketBeat, the stock currently has an average rating of “Moderate Buy” and a consensus target price of $37.00.

Heartflow Company Profile

HeartFlow, Inc (NASDAQ: HTFL) is a medical technology company that develops non-invasive diagnostic solutions for coronary artery disease. The company’s core offering translates coronary CT angiography (CTA) data into a patient-specific, three-dimensional physiological model of the coronary arteries. Using advanced image processing and computational modeling, HeartFlow’s analysis estimates fractional flow reserve (FFR) values throughout the coronary tree to identify ischemia-producing lesions without the need for invasive pressure-wire measurements.

HeartFlow’s cloud-based service integrates with clinical workflows: clinicians submit coronary CTA images and receive a detailed, color-coded 3D map and report that highlights lesion-specific FFR values and physiological impact.